Altman, Doxorubicin pathways: pharmacodynamics and adverse effects
[10] Recent therapeutics strategies have prioritized incretin-based therapies, notably glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide (Ozempic , Wegovy ) and liraglutide (Victoza ), which improve glycemic control, reduce glycated hemoglobin (HbA1c), and promote weight loss
It can then interact with the parts of the brain that reduce appetite and signal fullness, according to the FDA
Fluorescent probes for intracellular zinc detection Fluorescence-based sensors are the most widely used tools for monitoring intracellular zinc, particularly the labile zinc pool in living cells
Dave Moore who is the President of Novo Nordisk Inc
Thank you for being a vital part of our podcast community